Stockscreener 앱 받기
23.30
1.39%
0.32
시간 외 거래:
23.30
전일 마감가:
$22.98
열려 있는:
$23.06
하루 거래량:
701.60K
Relative Volume:
0.93
시가총액:
$1.25B
수익:
$312.78M
순이익/손실:
$-143.56M
주가수익비율:
-8.6617
EPS:
-2.69
순현금흐름:
$1.22M
1주 성능:
+4.30%
1개월 성능:
+8.83%
6개월 성능:
+16.56%
1년 성능:
+172.20%
1일 변동 폭
$22.86
$23.80
1주일 범위
$21.54
$23.80
52주 변동 폭
$7.42
$34.84
Caredx Inc Stock (CDNA) Company Profile
명칭
Caredx Inc
전화
415-287-2300
주소
8000 MARINA BLVD, BRISBANE, CA
CDNA을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
CDNA
Caredx Inc
|
23.30 | 1.25B | 312.78M | -143.56M | 1.22M | -2.69 |
|
TMO
Thermo Fisher Scientific Inc
|
597.75 | 228.64B | 42.88B | 6.34B | 7.27B | 16.53 |
|
DHR
Danaher Corp
|
222.74 | 160.17B | 23.88B | 3.90B | 5.30B | 5.28 |
|
A
Agilent Technologies Inc
|
151.52 | 43.27B | 6.51B | 1.29B | 1.37B | 4.42 |
|
IQV
Iqvia Holdings Inc
|
201.36 | 36.55B | 15.32B | 1.41B | 1.96B | 7.62 |
|
IDXX
Idexx Laboratories Inc
|
422.05 | 34.56B | 3.84B | 866.24M | 792.60M | 10.37 |
Caredx Inc Stock (CDNA) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2025-01-15 | 업그레이드 | Wells Fargo | Underweight → Equal Weight |
| 2024-08-28 | 개시 | Wells Fargo | Underweight |
| 2024-08-19 | 업그레이드 | BTIG Research | Neutral → Buy |
| 2024-05-13 | 다운그레이드 | Raymond James | Outperform → Mkt Perform |
| 2024-05-01 | 업그레이드 | Craig Hallum | Hold → Buy |
| 2023-11-09 | 업그레이드 | Stephens | Equal-Weight → Overweight |
| 2023-08-15 | 업그레이드 | Raymond James | Mkt Perform → Outperform |
| 2023-05-11 | 다운그레이드 | BTIG Research | Buy → Neutral |
| 2023-03-07 | 다운그레이드 | Stephens | Overweight → Equal-Weight |
| 2023-03-03 | 다운그레이드 | Craig Hallum | Buy → Hold |
| 2023-03-03 | 다운그레이드 | Raymond James | Strong Buy → Mkt Perform |
| 2022-04-25 | 개시 | Stephens | Overweight |
| 2021-07-20 | 재개 | BTIG Research | Buy |
| 2021-06-03 | 개시 | Goldman | Buy |
| 2021-02-26 | 다운그레이드 | H.C. Wainwright | Buy → Neutral |
| 2020-10-30 | 재확인 | H.C. Wainwright | Buy |
| 2020-10-08 | 재확인 | H.C. Wainwright | Buy |
| 2020-10-02 | 재확인 | H.C. Wainwright | Buy |
| 2020-08-05 | 재확인 | H.C. Wainwright | Buy |
| 2020-06-26 | 개시 | BTIG Research | Buy |
| 2020-06-19 | 재확인 | H.C. Wainwright | Buy |
| 2019-10-01 | 재개 | Craig Hallum | Buy |
| 2019-05-09 | 업그레이드 | H.C. Wainwright | Neutral → Buy |
| 2019-02-15 | 개시 | Jefferies | Buy |
| 2018-10-23 | 재개 | Raymond James | Strong Buy |
| 2018-09-18 | 재확인 | H.C. Wainwright | Neutral |
| 2017-11-27 | 개시 | H.C. Wainwright | Buy |
| 2016-06-14 | 재확인 | Mizuho | Buy |
| 2015-09-29 | 다운그레이드 | Raymond James | Outperform → Mkt Perform |
| 2015-09-25 | 개시 | Craig Hallum | Buy |
| 2015-03-18 | 재확인 | Mizuho | Buy |
모두보기
Caredx Inc 주식(CDNA)의 최신 뉴스
CareDx, Inc (NASDAQ:CDNA): Are Analysts Optimistic? - Simply Wall St
CareDx, Inc (NASDAQ:CDNA) Given Average Rating of "Moderate Buy" by Analysts - MarketBeat
Vanguard Group Inc. Increases Stake in CareDx Inc. - GuruFocus.com
Is CareDx (CDNA) Outperforming Other Medical Stocks This Year? - Yahoo Finance
CareDx (CDNA) Traded Down Due to Disappointing Quarterly Results - MSN
CareDx (NASDAQ:CDNA) Trading Down 5.4%Should You Sell? - MarketBeat
Here’s Why CareDx (CDNA) Traded Lower in Q4 - Insider Monkey
Leidos teams with CareDx to transform the Organ Procurement and Transplantation Network - Leidos
Best Momentum Stocks to Buy for January 21st - Yahoo Finance
Wells Fargo upgrades CareDx after a 30% pullback in stock - MSN
CareDx, Inc (NASDAQ:CDNA) Sees Significant Growth in Short Interest - MarketBeat
Implied Volatility Surging for CareDx (CDNA) Stock Options - MSN
CareDx guides Q4 revenue above estimates - MSN
FY2024 Earnings Forecast for CareDx Issued By HC Wainwright - Defense World
Strength Seen in CareDx (CDNA): Can Its 6.1% Jump Turn into More Strength? - MSN
First Week of March 21st Options Trading For CareDx (CDNA) - Nasdaq
What is HC Wainwright's Estimate for CareDx FY2024 Earnings? - MarketBeat
Wells Fargo & Company Upgrades CareDx (NASDAQ:CDNA) to Equal Weight - Defense World
CareDx Inc (CDNA) Shares Gap Down to $21.13 on Jan 16 - GuruFocus.com
CareDx, Inc Provides Preliminary Earnings Guidance for the Fourth Quarter and Full Year Ended December 31, 2024 and Provides Revenue Guidance for the Year 2025 - Marketscreener.com
Wells Fargo Upgrades CareDx (CDNA) - MSN
Wells Fargo upgrades CareDx, but lowers price target - MSN
CareDx sees Q4 revenue $85M-$86M, consensus $82.16M - MSN
Wells Fargo upgrades CareDx, but lowers price target (CDNA:NASDAQ) - Seeking Alpha
CareDx (NASDAQ:CDNA) Stock Rating Upgraded by Wells Fargo & Company - MarketBeat
Breaking Down CareDx: 3 Analysts Share Their Views - Benzinga
CareDx Inc (CDNA) Trading Down 4.47% on Jan 14 - GuruFocus.com
CareDx (NASDAQ:CDNA) Trading Down 6.1%Should You Sell? - MarketBeat
CareDx (NASDAQ:CDNA) Earns Neutral Rating from HC Wainwright - MarketBeat
CareDx (NASDAQ:CDNA) Sees Large Volume IncreaseTime to Buy? - MarketBeat
CareDx anticipates 30% revenue growth in fourth quarter By Investing.com - Investing.com South Africa
CareDx anticipates 30% revenue growth in fourth quarter - Investing.com India
CareDx Announces Strong Revenue Growth and Outlook - TipRanks
CareDx Announces Preliminary Fourth Quarter and Full Year 2024 Results - Business Wire
Catherine Wood's Strategic Reduction in CareDx Inc Holdings - GuruFocus.com
How to Take Advantage of moves in (CDNA) - Stock Traders Daily
CareDx revises compensation policy for board members By Investing.com - Investing.com Australia
CareDx, Inc. Adopts Amendments to Outside Director Compensation PolicyOn January 6, 2025, CareDx, Inc. (NASDAQ: CDNA) made updates to its outside director compensation policy. The Compensation and Human Capital Committee of the Board of Direct - Defense World
CareDx revises compensation policy for board members - Investing.com India
CareDx Updates Director Compensation and Vesting Policies - TipRanks
Caredx Inc (CDNA) 재무 분석
매출
순이익
현금흐름
주당 순 이익
0.69%
0.37%
자본화:
|
볼륨(24시간):